Benzinga | Aug 3, 2021 07:13AM EDT

Seres Therapeutics Q2 Sales $5.26M Miss $5.34M Estimate

Seres Therapeutics (NASDAQ:MCRB) reported quarterly sales of $5.26 million which missed the analyst consensus estimate of $5.34 million by 1.44 percent. This is a 12.94 percent decrease over sales of $6.04 million the same period last year.